A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-384 in Elderly Subjects.
Phase of Trial: Phase I
Latest Information Update: 23 Nov 2010
At a glance
- Drugs ABT 384 (Primary)
- Indications Neurological disorders
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 25 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 02 Nov 2009 New trial record